Alaunos TherapeuticsTCRT
13F holders, Q3 2025 (September 30)26holders −2
4new positions
6sold out
$2.42avg. 13F price*
At the end of Q3 2025, 26 institutions reported holding Alaunos Therapeutics Inc. (TCRT) in their 13F filings, down 2 from Q2 2025. 4 opened new positions and 6 sold out. The largest holders were BlackRock, Inc. ($51K), Vanguard Group Inc. ($51K) and Geode Capital Management, LLC ($39K).
- Company
- Alaunos Therapeutics Inc.
- CUSIP
- 98973P309
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $376 |
| Exits | 6 | $2K |
All 13F filers, Q2 2025 → Q3 2025: 1,488 shares bought and 7,118 shares sold, net −5,630 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| BlackRock, Inc. | 0.00% | No change | 21,353 | $51K |
| Vanguard Group Inc. | 0.00% | No change | 20,972 | $51K |
| Geode Capital Management, LLC | 0.00% | Reduce -1.0% | 15,791 | $39K |
| Morgan Stanley | 0.00% | Reduce -6.3% | 1,684 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +67.8% | 1,633 | $4K |
| UBS Group AG | 0.00% | Reduce -77.5% | 1,533 | $4K |
| Osaic Holdings, Inc. | 0.00% | Add +67.6% | 1,165 | $3K |
| CIBC Private Wealth Group LLC | 0.00% | No change | 300 | $723 |
| Wells Fargo & Company | 0.00% | No change | 183 | $441 |
| Blue Trust, Inc. | 0.00% | New | 135 | $325 |
| Steward Partners Investment Advisory, LLC | 0.00% | Reduce -91.6% | 92 | $222 |
| Bank of America Corp. | 0.00% | Add +4.7% | 89 | $214 |
| Federation des caisses Desjardins du Quebec | 0.00% | Reduce -18.6% | 70 | $169 |
| Barclays PLC | 0.00% | Reduce -50.0% | 50 | $121 |
| Asset Dedication, LLC | 0.00% | No change | 46 | $111 |
| Key Financial Inc | 0.00% | No change | 24 | $60 |
| NFSG Corp | 0.00% | No change | 24 | $58 |
| Signaturefd, LLC | 0.00% | No change | 23 | $55 |
| Lanark Financial, Inc. | 0.00% | New | 20 | $48 |
| AdvisorNet Financial, Inc | 0.00% | No change | 19 | $46 |
| Sunbelt Securities, Inc. | 0.00% | No change | 10 | $24 |
| BNP Paribas Financial Markets | 0.00% | No change | 6 | $15 |
| Wealthspire Advisors, LLC | 0.00% | New | 1 | $3 |
| Truvestments Capital LLC | 0.00% | No change | 1 | $2 |
| Royal Bank of Canada | 0.00% | New | 198 | $0 |
| Cwm, LLC | 0.00% | No change | 8 | $0 |
"% of holder's portfolio" is TCRT's weight in each manager's 13F, not the share of Alaunos Therapeutics Inc. the manager owns.